Evidence map›Paper›PMID 33495632›Full record

ArticleNature cell biology2021

Ribosomopathy-associated mutations cause proteotoxic stress that is alleviated by TOR inhibition.

Carles Recasens-Alvarez, Cyrille Alexandre, Joanna Kirkpatrick, Hisashi Nojima, David J Huels, Ambrosius P Snijders, Jean-Paul Vincent

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Systematic analysis of noncanonical ribosomal protein paralogs does not provide evidence for specialized functions inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 3 countries.

Carles Recasens-AlvarezThe Francis Crick Institute, London, UK. carles.recasensalvarez@crick.ac.uk.ORCID http://orcid.org/0000-0003-1405-458X
Cyrille AlexandreThe Francis Crick Institute, London, UK.
Joanna KirkpatrickThe Francis Crick Institute, London, UK.
Hisashi NojimaThe Francis Crick Institute, London, UK.
David J HuelsThe Francis Crick Institute, London, UK.
Ambrosius P SnijdersThe Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-5416-8592
Jean-Paul VincentThe Francis Crick Institute, London, UK. jp.vincent@crick.ac.uk.ORCID http://orcid.org/0000-0003-2305-5744
The Francis Crick Institute · GB

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
Medical Research Council FC001204NIH HHS P40 OD018537Wellcome Trust 206341/Z/17/Z
6 · The paper itself

Abstract

Ribosomes are multicomponent molecular machines that synthesize all of the proteins of living cells. Most of the genes that encode the protein components of ribosomes are therefore essential. A reduction in gene dosage is often viable albeit deleterious and is associated with human syndromes, which are collectively known as ribosomopathies

Indexed as

AllelesAnimalsApoptosisAutophagyDrosophila melanogasterHEK293 CellsHeterozygoteHumansImaginal DiscsMutationProtein AggregatesProtein BiosynthesisProteinsProteomicsRibosomal ProteinsRibosomesProtein AggregatesProteinsRibosomal ProteinsTOR Serine-Threonine Kinases

Identifiers

PMID33495632
PMCPMC7116740
OpenAlexW3125823424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.